Argent BioPharma (ASX:RGT) disclosed that all ten resolutions put to shareholders at its Annual General Meeting held on 20 November 2026 were carried, with voting conducted by poll across every motion, including the election of a new director and several approvals related to convertible notes and options.
Key Points
- All ten resolutions were passed by poll at the Annual General Meeting held on 20 November 2026.
- Andrew Chapman was elected as a new director, with 99.62% of votes cast in favour.
- Roby Zomer was re-elected as director, receiving 99.61% of votes in favour.
- Resolution 8, approving the issue of convertible notes and options for the balance drawdown, passed with 76.51% of votes in favour and 23.49% against.
- The Approval of the 7.1A Mandate passed with 99.70% of votes in favour.
Director Election and Re-Election Outcomes
Shareholders voted to elect Andrew Chapman as a director of Argent BioPharma, with 46,899,950 votes, representing 99.62% of votes cast, in favour and 176,762 votes, or 0.38%, against. The re-election of Roby Zomer, who serves as CEO and Managing Director, was also carried, with 46,895,132 votes, or 99.61%, in favour and 182,019 votes, or 0.39%, against. Both resolutions were decided by poll, in accordance with ASX Listing Rule 3.13.2.
Convertible Notes, Options, and Performance Rights Approvals
Shareholders approved the ratification of a prior issue of convertible notes with 99.75% in favour, and the ratification of a prior issue of advisory options with 99.55% support. Approval to issue options related to the July drawdown was carried with 99.61% in favour. Approval to issue convertible notes and options for the August drawdown passed with 99.55% support. Resolution 8, covering the approval to issue convertible notes and options for the balance drawdown, passed with 76.51% in favour and 23.49% against. The approval to issue performance rights under the NLC passed with 99.70% in favour.
Remuneration Report and 7.1A Mandate
The adoption of the Remuneration Report was carried with 26,374,631 votes, representing 99.33% of valid votes cast, in favour, while 178,510 votes, or 0.67%, were cast against, and 6,028,358 votes were recorded as abstentions. The Approval of the 7.1A Mandate was passed with 46,928,018 votes, equating to 99.70% in favour, and 141,314 votes, or 0.30%, against. All resolutions across the meeting were determined by poll.




Please wait processing your request...